HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 178 filers reported holding HAEMONETICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $551 | +6.4% | 7 | 0.0% | 0.00% | – |
| Q3 2022 | $518 | +13.6% | 7 | 0.0% | 0.00% | – |
| Q2 2022 | $456 | -51.9% | 7 | -53.3% | 0.00% | – |
| Q1 2022 | $948 | +155.5% | 15 | +114.3% | 0.00% | – |
| Q4 2021 | $371 | -97.2% | 7 | -93.9% | 0.00% | -100.0% |
| Q3 2018 | $13,177 | +5.0% | 115 | -17.9% | 0.01% | 0.0% |
| Q2 2018 | $12,555 | -79.1% | 140 | -82.9% | 0.01% | -79.1% |
| Q1 2018 | $60,064 | +26.0% | 821 | 0.0% | 0.04% | +22.9% |
| Q4 2017 | $47,684 | +29.4% | 821 | 0.0% | 0.04% | +25.0% |
| Q3 2017 | $36,838 | +13.6% | 821 | 0.0% | 0.03% | +7.7% |
| Q2 2017 | $32,421 | -2.7% | 821 | 0.0% | 0.03% | -7.1% |
| Q1 2017 | $33,308 | +0.9% | 821 | 0.0% | 0.03% | -6.7% |
| Q4 2016 | $33,004 | +11.0% | 821 | 0.0% | 0.03% | +11.1% |
| Q3 2016 | $29,728 | +24.9% | 821 | 0.0% | 0.03% | +22.7% |
| Q2 2016 | $23,801 | -44.2% | 821 | -32.6% | 0.02% | -45.0% |
| Q1 2016 | $42,641 | – | 1,219 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |